{"prompt": "['AVANOS', 'Genicular Nerve Lesion Study', 'Confidential', 'Protocol # 105-17-0001', 'new adverse events have occurred. Adverse Events will be assessed from the time the subject signs', 'consent until study exit. All adverse events must be reported according to the following procedure.', 'Sites will be instructed to follow their normal /routine processes for adverse event reporting of post market', 'products to the FDA per 803.20 - Individual Adverse Event Reports, however; related events that result in', 'death, serious injury or malfunction that could cause death or serious injury will be specifically monitored', 'for. As an additional measure of control, the sponsor will periodically review reported events as described', 'in section 11.6 looking for items that meet the reporting criteria.', '11.1.1 Definitions and Classification', 'Adverse Event (AE):', 'Any untoward medical occurrence that occurs in a subject or clinical investigation subject using a study', 'device including any unfavorable and unintended sign (including abnormal laboratory finding), symptom,', 'or disease temporally associated with the use of the study device, whether or not considered related to', 'the device.', 'Treatment Emergent Adverse Event (TEAE):', 'An AE that begins or worsens in severity after the subject has used at least one study device', 'Non-Treatment Emergent Adverse Event:', 'An AE that begins or worsens in severity between the time that the consent form is signed and', 'the first use of the study device', 'Serious Adverse Event (SAE):', 'A Serious Adverse Event is defined as any untoward medical occurrence that falls into one of the', 'following categories:', 'A.', 'Results in death', 'B.', 'Is life threatening, meaning that the subject is at risk of death at the time of the event; this', 'does not mean that the event hypothetically might have caused death if it were more', 'severe.', 'C.', 'Requires inpatient hospitalization or prolongation of existing hospitalization', 'D.', 'Results in persistent or significant disability or incapacity', 'E.', \"Is a congenital anomaly or birth defect in a subject's fetus or baby\", 'F.', 'Is an important medical event that may not be immediately life-threatening or result in', 'death or hospitalization, but that may jeopardize the subject or require intervention to', 'prevent one of the above outcomes. Examples of such events are intensive treatment in', 'an emergency room or at home for allergic bronchospasm, blood dyscrasias, or', 'convulsions that do not result in hospitalization.', 'Version #: 4.0', 'Page 33 of 62', 'Version Date: 28Mar19']['AVANOS', 'Genicular Nerve Lesion Study', 'Confidential', 'Protocol # 105-17-0001', 'Unanticipated Adverse Device Effect (UADE):', 'Any serious adverse effect on health or safety or any life-threatening problem or death cause by, or', 'associated with, a device, if that effect, problem or death was not previously identified in nature, severity,', 'or degree of incidence in the investigational plan or application, or any other unanticipated serious', 'problem associated with the device that relates to the rights, safety, or welfare of subjects.', '11.2 SEVERITY OF ADVERSE EVENTS', 'The Investigator (or authorized delegate) will assess the severity of each AE based on the following', 'definitions:', 'Severity', 'Definition', 'Mild', 'An AE in which the subject is aware of signs or symptoms, but which does not interfere with', \"the subject's usual activities of daily living, or is transient and resolves without treatment or\", 'sequelae', 'Moderate', \"A sign or symptom which interferes with the subject's usual activities of daily living or\", 'requires treatment', 'Severe', 'An AE that results in incapacity with inability to do work or do usual activities of daily living.', 'Severe AEs require treatment or medical intervention to resolve', '11.3', 'RELATIONSHIP OF ADVERSE EVENTS', 'For each AE, the Investigator (or qualified delegate) will assess the causality/relationship to the', 'investigational device according to the following criteria:', 'Relatedness', 'Definition', 'Unrelated', 'A clearly evident relationship to other etiologies, such as concomitant medications', \"or conditions or subject's known clinical state\", 'Unlikely', 'Based upon available information regarding subject history or disease process,', 'relationship of adverse event to test article(s) is unlikely', 'Possible', 'The association of the AE with the test article is unknown; other etiologies are also', 'possible', 'Version #: 4.0', 'Page 34 of 62', 'Version Date: 28Mar19']\n\n###\n\n", "completion": "END"}